Company / Profit Margin
Harmony Biosciences Holdings, Inc. Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
18.3%
FY2025
5-year range
-2535.1% / 41.4%
FY2021-FY2025
Trend
-10.3%
vs FY2024
Sector context
#29 of 145
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s profit margin of 18.3% is higher than 80% of companies in the Health Care sector (FY2025). Profit Margin has declined for 3 consecutive years, from 41.4% in FY2022 to 18.3% in FY2025.
Based on SEC 10-K filings.
18.3% in FY2025 with a 5-year CAGR of +2553.3%. Top quartile in the Health Care sector.
Declined from 22.1% to 18.3% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -23.2pp
- 5-Year Change
- +2553.3pp
- 10-Year Change
- -
Sector benchmark
+102.3% above sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s profit margin has declined for 3 consecutive years.
- In FY2025, profit margin decreased 10.3% year-over-year.
- Currently 811.0pp above the Health Care sector average.
- Peak profit margin was recorded in FY2022.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 18.3% | -10.3% |
| FY2024 | 20.4% | -8.0% |
| FY2023 | 22.1% | -46.6% |
| FY2022 | 41.4% | +101.6% |
| FY2021 | -2535.1% | +0.0% |
| FY2020 | -2535.1% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026